Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Zepp Health (ZEPP) EBITDA Margin: 2016-2025

Historic EBITDA Margin for Zepp Health (ZEPP) over the last 9 years, with Sep 2025 value amounting to -1.17%.

  • Zepp Health's EBITDA Margin rose 2836.00% to -1.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.70%, marking a year-over-year increase of 359.00%. This contributed to the annual value of -25.88% for FY2024, which is 1725.00% down from last year.
  • Latest data reveals that Zepp Health reported EBITDA Margin of -1.17% as of Q3 2025, which was up 88.64% from -10.27% recorded in Q2 2025.
  • In the past 5 years, Zepp Health's EBITDA Margin ranged from a high of 6.24% in Q2 2021 and a low of -1,331.91% during Q1 2022.
  • Over the past 3 years, Zepp Health's median EBITDA Margin value was -23.39% (recorded in 2023), while the average stood at -19.51%.
  • As far as peak fluctuations go, Zepp Health's EBITDA Margin slumped by 75,695bps in 2021, and later surged by 130,852bps in 2023.
  • Quarterly analysis of 5 years shows Zepp Health's EBITDA Margin stood at 0.61% in 2021, then crashed by 1,190bps to -11.29% in 2022, then spiked by 1,204bps to 0.75% in 2023, then plummeted by 1,577bps to -15.01% in 2024, then skyrocketed by 2,836bps to -1.17% in 2025.
  • Its last three reported values are -1.17% in Q3 2025, -10.27% for Q2 2025, and -47.68% during Q1 2025.